PTPA and glioblastoma: As shown in Fig. 3a, after exposure to PG (200 nM) for 24 h, the activity of PP2A was found to obviously increased in all GBM cell lines, and this increase was reversed by treatment with okadaic acid (OA; an inhibitor of PP2A).